Nurix Therapeutics Announces Upcoming Presentation of NX-5948 Preclinical Data at the EULAR 2021 Virtual Congress

NEXT STORY
Global Smartwatch Market Report 2021-2026: Market is Expected to Grow at the Rate of 19.5% CAGR
PREV STORY
BioNTech Publishes First Sustainability Report and Receives “Prime” Rating by ISS ESG
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Anthera Pharmaceuticals Announces Presentation at Healthcare Conferences, ACR Reception and Timing of Third Quarter Financial Results

HAYWARD, Calif., Oct. 28, 2015 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced the ...

author_avatar
NASDAQ Market News

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

Vasomune Therapeutics and AnGes, Inc. enter into a Multi-Million Dollar Global Co-Development Agreement to Advance an Innovative Platform Targeting Vascular Leakage

author_avatar
NASDAQ Market News